Grupo Uriach (Seller)Galenica (Buyer)
Galenica purchasing Vifor Uriach Pharma, its 50/50 JV with Grupo Uriach, and Grupo Uriach's primary care business.
Fresenius (Other)Galenica (Other)
Galenica and Fresenius formed a JV, called Vifor-Fresenius Medical Care Renal Pharma Ltd., to develop and market products to treat iron deficiency anemia and bone mineral metabolism
Set Email Alert